We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEN
2326
DELISTED
Blackrock Muni Enhanced Fund, Inc.
MEN
$809K ﹤0.01%
72,856
+6,336
+10% +$68.6K
AMPH icon
2327
Amphastar Pharmaceuticals
AMPH
$869M
$807K ﹤0.01%
38,231
+1,944
+5% +$40.6K
CHWY icon
2328
Chewy
CHWY
$9.2B
$807K ﹤0.01%
+23,070
New +$779K
AFG icon
2329
American Financial Group
AFG
$12B
$803K ﹤0.01%
7,838
-968
-11% -$97.3K
STM icon
2330
STMicroelectronics
STM
$49.1B
$803K ﹤0.01%
45,567
-95,983
-68% -$1.62M
GATX icon
2331
GATX Corp
GATX
$6.27B
$802K ﹤0.01%
10,119
-3,630
-26% -$276K
ADT icon
2332
ADT
ADT
$5.44B
$800K ﹤0.01%
130,738
+700
+0.5% +$4.46K
BGIO
2333
DELISTED
BlackRock 2022 Global Income Opportunity Trust
BGIO
$795K ﹤0.01%
84,102
-36,665
-30% -$337K
MFIC icon
2334
MidCap Financial Investment
MFIC
$804M
$790K ﹤0.01%
49,981
+15,324
+44% +$241K
SCHF icon
2335
Schwab International Equity ETF
SCHF
$68.5B
$789K ﹤0.01%
49,174
-29,982
-38% -$474K
WPP icon
2336
WPP
WPP
$5.83B
$789K ﹤0.01%
12,539
+1,243
+11% +$75.4K
CCLP
2337
DELISTED
CSI Compressco LP
CCLP
$788K ﹤0.01%
222,461
+1,840
+0.8% +$5.95K
NAC icon
2338
Nuveen California Quality Municipal Income Fund
NAC
$1.85B
$787K ﹤0.01%
54,373
-7,817
-13% -$110K
EUFN icon
2339
iShares MSCI Europe Financials ETF
EUFN
$4.27B
$786K ﹤0.01%
43,294
-8,734
-17% -$164K
MZTI
2340
The Marzetti Company
MZTI
$3.15B
$786K ﹤0.01%
5,287
-94
-2% -$14.1K
PSP icon
2341
Invesco Global Listed Private Equity ETF
PSP
$249M
$786K ﹤0.01%
13,166
-692
-5% -$40.9K
BT
2342
DELISTED
BT Group plc (ADR)
BT
$785K ﹤0.01%
61,436
+18,160
+42% +$252K
MLPI
2343
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
$784K ﹤0.01%
35,105
+517
+1% +$11.5K
CPA icon
2344
Copa Holdings
CPA
$5.49B
$780K ﹤0.01%
7,991
-12
-0.1% -$1.06K
ACB
2345
Aurora Cannabis
ACB
$216M
$776K ﹤0.01%
827
+380
+85% +$382K
NWBI icon
2346
Northwest Bancshares
NWBI
$2.29B
$772K ﹤0.01%
43,815
-3,000
-6% -$51.5K
ACP
2347
abrdn Income Credit Strategies Fund
ACP
$641M
$770K ﹤0.01%
64,405
-1,568
-2% -$19K
MCI
2348
Barings Corporate Investors
MCI
$340M
$770K ﹤0.01%
49,184
+6,455
+15% +$101K
MDYV icon
2349
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.87B
$768K ﹤0.01%
14,942
+9,812
+191% +$500K
IBKC
2350
DELISTED
IBERIABANK Corp
IBKC
$767K ﹤0.01%
10,118
+99
+1% +$7.52K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.